Condensed Consolidated Statements of Operations - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
| Revenues | ||||
| Total revenue | $ 4,074,786 | $ 25,037,592 | $ 13,342,699 | $ 25,579,597 |
| Operating expenses: | ||||
| Cost of product sales | 3,111,290 | 0 | 5,397,872 | 0 |
| Research and development | 1,047,877 | 964,574 | 3,780,352 | 2,411,293 |
| Acquired in-process research and development, including transaction costs | 18,723,952 | 0 | 18,723,952 | 0 |
| General and administrative | 1,884,293 | 2,151,859 | 7,833,612 | 4,921,269 |
| Sales and marketing | 2,310,760 | 0 | 5,889,137 | 0 |
| Amortization expense | 1,065,398 | 0 | 3,315,843 | 0 |
| Impairment of intangible assets | 159,687 | 0 | 1,861,562 | 0 |
| Total operating expenses | 28,303,257 | 3,116,433 | 46,802,330 | 7,332,562 |
| (Loss) income from operations | (24,228,471) | 21,921,159 | (33,459,631) | 18,247,035 |
| Other (expense) income: | ||||
| Change in fair value of contingent consideration, warrant liability and unit purchase option liability | (87,838) | 64 | (383,179) | (1,586) |
| Other income | 0 | 0 | 18,655 | 0 |
| Interest (expense) income, net | (234,854) | 29,387 | (577,664) | (53,991) |
| Total other (expense) income, net | (322,692) | 29,451 | (942,188) | (55,577) |
| Net (loss) income before taxes | (24,551,163) | 21,950,610 | (34,401,819) | 18,191,458 |
| Income tax expense | 52,412 | 3,230,000 | 92,076 | 3,230,000 |
| Net (loss) income | $ (24,603,575) | $ 18,720,610 | $ (34,493,895) | $ 14,961,458 |
| Net income (loss) per share of common stock, basic and diluted (in dollars per share) | $ (0.71) | $ 0.52 | $ (1.05) | $ 0.65 |
| Weighted average shares of common stock outstanding, basic (in shares) | 34,648,641 | 21,382,683 | 32,749,291 | 14,952,391 |
| Weighted average shares of common stock outstanding, diluted (in shares) | 34,648,641 | 21,407,702 | 32,749,291 | 14,960,032 |
| Product revenue, net | ||||
| Revenues | ||||
| Total revenue | $ 4,074,786 | $ 0 | $ 13,045,824 | $ 0 |
| Sales force revenue | ||||
| Revenues | ||||
| Total revenue | 0 | 0 | 296,875 | 0 |
| License and other revenue | ||||
| Revenues | ||||
| Total revenue | 0 | 25,000,000 | 0 | 25,000,000 |
| Grant revenue | ||||
| Revenues | ||||
| Total revenue | $ 0 | $ 37,592 | $ 0 | $ 579,597 |
| X | ||||||||||
- Definition Fair Value Adjustment of Warrants And Investor Rights Obligation And Contingent Consideration No definition available.
|
| X | ||||||||||
- Definition Net Income (Loss) Before Taxes No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of nonoperating interest income (expense). No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. No definition available.
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|